Family-owned drug factories in India erode US generic pricesPost published:August 31, 2017Post category:Industry NewsExpansion by Indian pharma firms is boosting competition in the US, where mergers and pricing wars among drugmakers had already been driving down cost of generics Source: Livemint.com (http://www.livemint.com/rss/industry)Read more articles Previous PostRBI mandates 50% provisioning for NCLT cases Next PostHow Nandan Nilekani returned to Infosys You Might Also Like Bank employees body questions need for turnaround plan for 10 weak govt banks June 28, 2017 ADB to lend $175 million to Power Grid for transmission project April 7, 2017 Why Manufacturers are Stoked about IIoT March 27, 2018